Earlier this month, I had the good fortune to attend the “Keystone Joint Symposia” event in Keystone, Colo. (and yes, it was much colder than at Antibody Solutions’ headquarters in Sunnyvale, Calif.!).The speakers during the sessions had two primary goals: (1) to present the most recent advances in the biology of T cell-dependent B cell responses; and (2) to explore how our understanding of B-T cell interactions influence antibody generation and inform vaccine development.
We are occasionally asked about the success rate of different antibody platforms for drug discovery. There are a variety of technologies available for therapeutic antibody discovery: conventional mice where the Abs are humanized, human Ab transgenic rodents, human Ab synthetic phage and yeast libraries, and others.
Antibody Solutions will be attending PepTalk 2019, to be held January 14-18 in San Diego, CA.
Antibody Solutions will be attending Keystone Symposia's Molecular Approaches 2019, to be held February 10-15 in Keystone, CO.
Antibody Solutions will be attending PEGS 2019, to be held April 8-12 in Boston, MA.
Antibody Solutions will be attending Next Generation CAR & T Cell Therapies 2019, to be held June 18-20 in San Francisco, CA.
Antibody Solutions will be attending CAR-TCR Summit 2019, to be held September 10-13 in Boston, MA.
Antibody Solutions will be attending Discovery On Target 2019, to be held September 17-19 in Boston, MA.
Antibody Solutions will be attending PEGS Europe 2019, to be held November 18-22 in Lisbon, Portugal.
Antibody Solutions will be attending Antibody Engineering & Therapeutics 2019, to be held December 9-13 in San Diego, CA.
Antibody Solutions, a leader in discovery of therapeutic, biomarker and critical reagent antibodies, and Single Cell Technology, Inc. (SCT), a pioneer in single cell analysis technology, have launched a partnership that offers pharmaceutical researchers one-stop access to advanced single B-cell antibody discovery capabilities.